These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20069052)

  • 1. Simultaneous TIRF imaging of subplasmalemmal Ca
    Suckert C; Zosel C; Schaefer M
    Cell Calcium; 2024 Jun; 120():102883. PubMed ID: 38643716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling of insulin secretion and the role of glucose-dependent mobilization, docking, priming and fusion of insulin granules.
    Stamper IJ; Wang X
    J Theor Biol; 2013 Feb; 318():210-25. PubMed ID: 23154190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
    Malaisse WJ
    Treat Endocrinol; 2003; 2(6):401-14. PubMed ID: 15981944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
    Aoyagi K; Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Nagamatsu S
    Exp Diabetes Res; 2009; 2009():278762. PubMed ID: 20069052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nateglinide and mitiglinide, but not sulfonylureas, induce insulin secretion through a mechanism mediated by calcium release from endoplasmic reticulum.
    Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
    J Pharmacol Exp Ther; 2007 Jul; 322(1):1-7. PubMed ID: 17409272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
    Hu S; Wang S; Dunning BE
    Int J Exp Diabetes Res; 2001; 2(1):63-72. PubMed ID: 12369728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structures and mechanisms for non SU insulin secretagogues].
    Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
    [No Abstract]   [Full Text] [Related]  

  • 8. Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
    Bokvist K; Hoy M; Buschard K; Holst JJ; Thomsen MK; Gromada J
    Eur J Pharmacol; 1999 Dec; 386(1):105-11. PubMed ID: 10611470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of rise in subplasma membrane Ca2+ concentration determines type of fusing insulin granules in pancreatic beta cells.
    Ohara-Imaizumi M; Aoyagi K; Nakamichi Y; Nishiwaki C; Sakurai T; Nagamatsu S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):291-5. PubMed ID: 19426714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoskeleton and vesicle mobility in astrocytes.
    Potokar M; Kreft M; Li L; Daniel Andersson J; Pangrsic T; Chowdhury HH; Pekny M; Zorec R
    Traffic; 2007 Jan; 8(1):12-20. PubMed ID: 17229312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules.
    Nagamatsu S; Ohara-Imaizumi M; Nakamichi Y; Kikuta T; Nishiwaki C
    Diabetes; 2006 Oct; 55(10):2819-25. PubMed ID: 17003348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cofilin phosphatases and regulation of actin dynamics.
    Huang TY; DerMardirossian C; Bokoch GM
    Curr Opin Cell Biol; 2006 Feb; 18(1):26-31. PubMed ID: 16337782
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.